168 related articles for article (PubMed ID: 16803455)
1. Statins inhibit the dimerization of beta-secretase via both isoprenoid- and cholesterol-mediated mechanisms.
Parsons RB; Price GC; Farrant JK; Subramaniam D; Adeagbo-Sheikh J; Austen BM
Biochem J; 2006 Oct; 399(2):205-14. PubMed ID: 16803455
[TBL] [Abstract][Full Text] [Related]
2. Statins cause intracellular accumulation of amyloid precursor protein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism.
Cole SL; Grudzien A; Manhart IO; Kelly BL; Oakley H; Vassar R
J Biol Chem; 2005 May; 280(19):18755-70. PubMed ID: 15718241
[TBL] [Abstract][Full Text] [Related]
3. The regulation of beta-secretase by cholesterol and statins in Alzheimer's disease.
Sidera C; Parsons R; Austen B
J Neurol Sci; 2005 Mar; 229-230():269-73. PubMed ID: 15760650
[TBL] [Abstract][Full Text] [Related]
4. Statins reduce amyloid-beta production through inhibition of protein isoprenylation.
Ostrowski SM; Wilkinson BL; Golde TE; Landreth G
J Biol Chem; 2007 Sep; 282(37):26832-26844. PubMed ID: 17646164
[TBL] [Abstract][Full Text] [Related]
5. Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-beta protein precursor processing by suppression of cholesterol synthesis.
Kojro E; Füger P; Prinzen C; Kanarek AM; Rat D; Endres K; Fahrenholz F; Postina R
J Alzheimers Dis; 2010; 20(4):1215-31. PubMed ID: 20413873
[TBL] [Abstract][Full Text] [Related]
6. A specific inhibitor of cholesterol biosynthesis, BM15.766, reduces the expression of beta-secretase and the production of amyloid-beta in vitro.
Parsons RB; Subramaniam D; Austen BM
J Neurochem; 2007 Aug; 102(4):1276-91. PubMed ID: 17472704
[TBL] [Abstract][Full Text] [Related]
7. Post-translational processing of beta-secretase in Alzheimer's disease.
Sidera C; Parsons R; Austen B
Proteomics; 2005 Apr; 5(6):1533-43. PubMed ID: 15789346
[TBL] [Abstract][Full Text] [Related]
8. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L
Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the lipidation of beta-secretase by statins.
Parsons RB; Farrant JK; Price GC; Subramaniam D; Austen BM
Biochem Soc Trans; 2007 Jun; 35(Pt 3):577-82. PubMed ID: 17511656
[TBL] [Abstract][Full Text] [Related]
10. Protein-protein interactions in the assembly and subcellular trafficking of the BACE (beta-site amyloid precursor protein-cleaving enzyme) complex of Alzheimer's disease.
Parsons RB; Austen BM
Biochem Soc Trans; 2007 Nov; 35(Pt 5):974-9. PubMed ID: 17956258
[TBL] [Abstract][Full Text] [Related]
11. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
Luan Z; Chase AJ; Newby AC
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370
[TBL] [Abstract][Full Text] [Related]
12. Toward prevention of Alzheimers disease--potential nutraceutical strategies for suppressing the production of amyloid beta peptides.
McCarty MF
Med Hypotheses; 2006; 67(4):682-97. PubMed ID: 16828233
[TBL] [Abstract][Full Text] [Related]
13. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation.
Maeda T; Kawane T; Horiuchi N
Endocrinology; 2003 Feb; 144(2):681-92. PubMed ID: 12538631
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol Intervenes Cholesterol- and Isoprenoid-Mediated Amyloidogenic Processing of AβPP in Familial Alzheimer's Disease.
Sathya M; Moorthi P; Premkumar P; Kandasamy M; Jayachandran KS; Anusuyadevi M
J Alzheimers Dis; 2017; 60(s1):S3-S23. PubMed ID: 28059793
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of statins in an in vitro model of Alzheimer's disease.
Fonseca AC; Proença T; Resende R; Oliveira CR; Pereira CM
J Alzheimers Dis; 2009; 17(3):503-17. PubMed ID: 19363255
[TBL] [Abstract][Full Text] [Related]
16. Gamma-secretase activity is present in rafts but is not cholesterol-dependent.
Wada S; Morishima-Kawashima M; Qi Y; Misono H; Shimada Y; Ohno-Iwashita Y; Ihara Y
Biochemistry; 2003 Dec; 42(47):13977-86. PubMed ID: 14636066
[TBL] [Abstract][Full Text] [Related]
17. Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways.
Kotamraju S; Williams CL; Kalyanaraman B
Cancer Res; 2007 Aug; 67(15):7386-94. PubMed ID: 17671209
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding.
Parvathy S; Ehrlich M; Pedrini S; Diaz N; Refolo L; Buxbaum JD; Bogush A; Petanceska S; Gandy S
J Neurochem; 2004 Aug; 90(4):1005-10. PubMed ID: 15287907
[TBL] [Abstract][Full Text] [Related]
19. Statins reduce amyloid β-peptide production by modulating amyloid precursor protein maturation and phosphorylation through a cholesterol-independent mechanism in cultured neurons.
Hosaka A; Araki W; Oda A; Tomidokoro Y; Tamaoka A
Neurochem Res; 2013 Mar; 38(3):589-600. PubMed ID: 23269484
[TBL] [Abstract][Full Text] [Related]
20. Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: role of BACE 1 in the constitutive secretory pathway.
Hook VY; Reisine TD
J Neurosci Res; 2003 Nov; 74(3):393-405. PubMed ID: 14598316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
